Nektar Therapeutics Financial Overview
Nektar Therapeutics's market cap is currently $1.17B. The company's EPS TTM is $-1.87; its P/E ratio is ―; Nektar Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-2.42. See an overview of income statement, balance sheet, and cash flow financials.
